Moreover, coupled with the associations in this review linking collagen, LOX, and MMP upregulation with breast cancer, these results indicate the potential for GLP-1 agonist incorporation into combinatorial regimens as a therapeutic strategy for breast cancer in obese patients. The gene discussed is LOX; the disease is breast carcinoma.